Pediatric Leukemia Clinic
Pediatric Leukemia Clinic
Yawkey Center for Outpatient Care
32 Fruit Street, Suite 8B
Boston, MA 02114
Explore This Clinic
Care During COVID-19
Our dedicated physicians, nurses and staff are committed to providing the best possible care for children. We have taken unprecedented steps to ensure office visits and procedures are welcoming and safe. Your child’s health and safety is our top priority.
Leukemia is the most common type of cancer diagnosed in children. It is a type of cancer of immature white blood cells that grow out of control and interfere with normal blood cell reduction. This results in anemia and an increased risk for infection and bleeding. Leukemia begins in the bone marrow, the spongy material in the center of our bones that is the factory for blood cell production.
There are four different types of leukemia in children:
- Acute lymphoblastic leukemia (ALL) 80%
- Acute myeloid leukemia (AML) 15%
- Chronic myeloid leukemia (CML) 2%
- Juvenile myelomonocytic leukemia (JMMC) 1%
Our leukemia program has state-of-the-art diagnosis and care and access to clinical trials. Our physicians work in consultation with leading hematopathologists and other specialists (blood bank, infectious disease, etc.) and provide compassionate and personalized care for all patients.
Expertise in Diagnosing Leukemia
The hematopathologists at Massachusetts General Hospital are world renowned for their expertise in the diagnosis of various types of childhood leukemia. The pathology department has state-of-the-art technology, including
- Advanced microscopy
- Flow cytometry for diagnosing subtypes of leukemia and detecting minimal residual disease
- Cytogenetic technologies to examine chromosomes of leukemia cells
- Molecular evaluation of leukemia for diagnostic, prognostic, and research purposes
Research and Clinical Trials
Clinical trials are research studies testing new drugs or combinations of already approved drugs in novel ways. The development of clinical trials over the past 40 years for children with leukemia has led to the high cure rates our patients enjoy today. We work with the Children's Oncology Group (COG), a national pediatric clinical trials group, to develop innovative therapies for childhood leukemia. In addition, we have collaborations with our adult leukemia specialists at Mass General to help identify new drug targets.
Learn more about the pediatric oncologists and other health care professionals on our team.
- Clinical Director, Pediatric Hematology/Oncology
- Assistant Professor, Harvard Medical School
- Assistant Professor Harvard Medical School
- Director - Long Term Follow-Up Clinic, MassGeneral Cancer Care for Children
- Chief of Medical Genetics and Metabolism, MGH
- Attending Physician in Pediatric Hematology/Oncology
- Co-Director Pitt Hopkins Clinic
- Unit Chief, Pediatric Hematology/Oncology